ATE256667T1 - Verbindungen und deren verwendung zur behandlung von infektiösen erkrankungen - Google Patents

Verbindungen und deren verwendung zur behandlung von infektiösen erkrankungen

Info

Publication number
ATE256667T1
ATE256667T1 AT96903481T AT96903481T ATE256667T1 AT E256667 T1 ATE256667 T1 AT E256667T1 AT 96903481 T AT96903481 T AT 96903481T AT 96903481 T AT96903481 T AT 96903481T AT E256667 T1 ATE256667 T1 AT E256667T1
Authority
AT
Austria
Prior art keywords
compounds
infectious diseases
treating infectious
salts
image
Prior art date
Application number
AT96903481T
Other languages
German (de)
English (en)
Inventor
Michael I Bukrinsky
Anthony Cerami
Peter Ulrich
Bradley J Berger
Original Assignee
Picower Inst Med Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/369,830 external-priority patent/US5574040A/en
Application filed by Picower Inst Med Res filed Critical Picower Inst Med Res
Application granted granted Critical
Publication of ATE256667T1 publication Critical patent/ATE256667T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/16—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/24—Y being a hetero atom
    • C07C279/26—X and Y being nitrogen atoms, i.e. biguanides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/40—Nitrogen atoms
    • C07D251/48—Two nitrogen atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT96903481T 1995-01-06 1996-01-05 Verbindungen und deren verwendung zur behandlung von infektiösen erkrankungen ATE256667T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/369,830 US5574040A (en) 1995-01-06 1995-01-06 Pyrimidine compounds and methods of use to derivatize neighboring lysine residues in proteins under physiologic conditions
US08/463,405 US5733932A (en) 1995-01-06 1995-06-05 Compounds and methods of use to derivatize neighboring lysine residues in proteins under physiological conditions
PCT/US1996/000486 WO1996020932A1 (en) 1995-01-06 1996-01-05 Compounds and methods of use to treat infectious diseases

Publications (1)

Publication Number Publication Date
ATE256667T1 true ATE256667T1 (de) 2004-01-15

Family

ID=27004718

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96903481T ATE256667T1 (de) 1995-01-06 1996-01-05 Verbindungen und deren verwendung zur behandlung von infektiösen erkrankungen

Country Status (7)

Country Link
US (4) US5733932A (en:Method)
EP (1) EP0865434B1 (en:Method)
AT (1) ATE256667T1 (en:Method)
AU (1) AU715844B2 (en:Method)
CA (1) CA2218561C (en:Method)
DE (1) DE69631158T2 (en:Method)
WO (1) WO1996020932A1 (en:Method)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9224739D0 (en) * 1992-11-26 1993-01-13 Wellcome Found Medicaments
US6297253B1 (en) * 1996-10-15 2001-10-02 The Picower Institute For Medical Research Compounds and methods of use to treat infectious diseases
AU2960000A (en) * 1999-01-08 2000-07-24 University Of Massachusetts Detection of human immunodeficiency virus
US6734192B1 (en) * 1999-08-23 2004-05-11 Mp-1 Inc. Treatment of viral infections
ES2154604B1 (es) * 1999-09-06 2001-11-16 Gonzalez Regueral Valdes Jose Medicacion de uso topico aplicable para el tratamiento de enfermedades producidas por virus, especialmente el herpes simplex de los tipos h sv1 y hsv2
DE60043397D1 (de) * 1999-12-28 2010-01-07 Pharmacopeia Inc Cytokine, insbesondere tnf-alpha, hemmer
US6906067B2 (en) 1999-12-28 2005-06-14 Bristol-Myers Squibb Company N-heterocyclic inhibitors of TNF-α expression
US20040127502A1 (en) 2001-01-31 2004-07-01 Synaptic Pharmaceutical Corporation Use of GAL3 antagonist for treatment of depression
US7081470B2 (en) * 2001-01-31 2006-07-25 H. Lundbeck A/S Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
TWI329105B (en) 2002-02-01 2010-08-21 Rigel Pharmaceuticals Inc 2,4-pyrimidinediamine compounds and their uses
US6797464B2 (en) * 2002-07-10 2004-09-28 University Of Massachusetts Detection of drug-resistant human immunodeficiency virus
JP2006514989A (ja) * 2002-07-29 2006-05-18 ライジェル ファーマシューティカルズ ２，４−ピリミジンジアミン化合物による自己免疫疾患の治療および予防方法
US20090018150A1 (en) * 2003-07-24 2009-01-15 Asterand Uk Limited 5-Ht2b Receptor Antagonists
AU2004265288A1 (en) 2003-07-30 2005-02-24 Rigel Pharmaceuticals, Inc. 2,4-pyrimidinediamine compounds for use in the treatment or prevention of autoimmune diseases
EP1814878B1 (en) 2004-11-24 2012-01-04 Rigel Pharmaceuticals, Inc. Spiro-2, 4-pyrimidinediamine compounds and their uses
EP1883302A4 (en) * 2005-05-03 2009-05-20 Rigel Pharmaceuticals Inc JAK KINASE HEMMER AND ITS USE
WO2006130832A2 (en) * 2005-06-02 2006-12-07 The General Hospital Corporation Anti-infective and immunomodulatory compounds

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3908013A (en) * 1970-09-17 1975-09-23 Armour Pharma Pharmaceutical aromatic guanidine compositions and methods of using same
DE2144583A1 (de) * 1970-11-10 1972-05-18 Armour Pharmaceutical Co., Chicago, 111. (V.StA.) Pharmazeutisches Präparat und Verfahren zu seiner Anwendung
US4051256A (en) * 1976-09-19 1977-09-27 Imperial Chemical Industries Limited Guanidine derivatives
DK130584A (da) * 1983-04-08 1984-10-09 Ciba Geigy Ag N-(2-nitrophenyl)-4-amino-pyrimidin-derivater samt deres fremstilling og anvendelse som mikrobicider
GB8510758D0 (en) * 1985-04-27 1985-06-05 Wellcome Found Compounds
JPH0629263B2 (ja) * 1985-10-30 1994-04-20 クミアイ化学工業株式会社 ピリミジン誘導体および農園芸用殺菌剤
US5093525A (en) * 1986-07-10 1992-03-03 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University N,N'-disubstituted guanidines and their use as excitatory amino acid antagonists
US4782062A (en) * 1987-05-11 1988-11-01 Merck & Co., Inc. 9-(2-hydroxymethyl)cycloalkylmethyl) guanines
US4900813A (en) * 1987-07-02 1990-02-13 Ciba-Geigy Corporation Fiber-reactive azo dyes having a 4,6-diaminopyridine coupling component
PH27460A (en) * 1989-12-28 1993-07-09 Kumiai Chemical Industry Co Pyrimidine derivatives and herbicidal composition containing the same
GB9012592D0 (en) * 1990-06-06 1990-07-25 Smithkline Beecham Intercredit Compounds
DE4120247A1 (de) * 1991-06-19 1992-12-24 Henkel Kgaa Neue tetraaminopyrimidin-derivate und deren verwendung in oxidationsfaerbemitteln
US5599984A (en) * 1994-01-21 1997-02-04 The Picower Institute For Medical Research Guanylhydrazones and their use to treat inflammatory conditions

Also Published As

Publication number Publication date
CA2218561A1 (en) 1996-07-11
EP0865434A1 (en) 1998-09-23
AU715844B2 (en) 2000-02-10
US5620983A (en) 1997-04-15
US5840893A (en) 1998-11-24
DE69631158D1 (de) 2004-01-29
AU4755996A (en) 1996-07-24
CA2218561C (en) 2009-09-15
EP0865434B1 (en) 2003-12-17
US5733932A (en) 1998-03-31
WO1996020932A1 (en) 1996-07-11
US5703086A (en) 1997-12-30
EP0865434A4 (en:Method) 1998-09-23
DE69631158T2 (de) 2004-08-26

Similar Documents

Publication Publication Date Title
ATE256667T1 (de) Verbindungen und deren verwendung zur behandlung von infektiösen erkrankungen
ATE220400T1 (de) Trizyklische verbindungen zur behandlung von zellproliferativen störungen
DE69113155D1 (de) 17-beta-substituierte-4-aza-5-alpha-androstan-3-one-derivate und verfahren zu ihrer herstellung.
DE69528273D1 (de) 1,2-substituierte imidazolylverbindungen zur behandlung von entzündungen
DE69823344D1 (de) Substituierte benzimidazol-derivaten und ihre verwendung zur behandlung retroviraler infektionen
DE69628556D1 (de) Tricyclische verbindungen als inhibitoren von farnesyl protein transferase
ATE303993T1 (de) 4-hydroxychinolin-3-carboxamide und hydrazide als antivirale wirkstoffe
DE69324120D1 (de) HIV-Proteaseinhibitoren und ihre Verwendung zur Behandlung von AIDS
ES2153851T3 (es) Tratamiento de la atrofia de la piel y de la vagina.
ATE206409T1 (de) N-(1-alkyl-5-phenyl-2,3,4,5-tetrahydro-1-h- benzo(b)(1,5)-diazepin-3-yl)-acetamide
ATE206110T1 (de) Zns-aktive semicarbazone und diese enthaltende pharmazeutische zubereitungen
MA22895A1 (fr) 7-(2-aminoethyl) benzothiazolones.
EA200001133A1 (ru) Антипикорнавирусные композиции, их получение и применение
NO843196L (no) Kondenserte 7-leddede ringforbindelser og fremgangsmaate for deres fresmtilling
ATE208765T1 (de) 2-amino-benzoxazinone zur behandlung von viralen infektionen
DE69610628D1 (de) N-(2,4-dioxo-2,3,4,5-tetrahydro-1h-1,5-benzodiazepin-3-yl)-3-amide
ES2194102T3 (es) Nuevas n-(2,4-dioxo-2,3,4,5-tetrahidro-1h-1,5-benzodiazepin-3-il)-3-amidas.
DE69127976D1 (de) Tropolonderivate und pharmazeutische zubereitungen davon zur vorbeugung und behandlung von ischämischen krankheiten
NO965097L (no) Nye elastaseinhibitorer
DE69307674D1 (de) HIV-Proteaseinhibitoren und ihre Verwendung zur Behandlung von AIDS
ATE157660T1 (de) Hydroxymethylfurazancarbonsäurederivate und ihre verwendung in der behandlung von kardiovaskulären erkrankungen
ES2137665T3 (es) Nuevos derivados de piridina o piridazina, procedimientos para su preparacion, y medicamentos que contienen estos compuestos.
DE68926222D1 (de) Verwendung von 1,2,3,4-Tetrahydroacridinen zur Behandlung von AIDS, sowie Verbindungen
DE69616801D1 (de) Eintopfverfahren zur herstellung von 2-oxazolidinonderivate
ATE168697T1 (de) Pyrrolidinderivate zur behandlung von cck und gastrin-abhängigen erkrankungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties